Back to Search
Start Over
Ahmed glaucoma valve augmented with mitomycin C and amniotic membrane as a first intervention in advanced primary congenital glaucoma.
- Source :
-
Journal of the Egyptian Ophthalmological Society . Jan-Mar2024, Vol. 117 Issue 1, p63-67. 5p. - Publication Year :
- 2024
-
Abstract
- Aim The goal of this study is to assess the effectiveness of implantation of an Ahmed glaucoma valve (AGV) augmented with the use of mitomycin-C (MMC) and preserved amniotic membrane (AM), as a first line of intervention in cases of advanced primary congenital glaucoma (PCG). Patients and methods Prospective clinical and interventional trial was done on 30 eyes of 24 patients, aged between 6 months and 3 years, with advanced PCG at presentation. AGV (model FP8) implantation augmented with use of MMC and two layers of cryopreserved human AM as a primary intervention. Results At all-time intervals (at day 1, 1, 3, and 12 months following surgery), the postoperative intraocular pressures (IOPs) were significantly lower than the preoperative IOPs (16.83±2.78 mmHg at month 12 compared with a preoperative IOP of 38.29±4.23 mmHg). At all times, the postoperative corneal diameter was not noticeably smaller than the preoperative values (13.79±0.57 mm at month 12 compared with preoperative value of 13.93±0.58 mm). Conclusion AGV augmented with the use of MMC and AM can be considered as a secure and reliable approach for management of cases of advanced PCG, without additional risks compared with other techniques. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20900686
- Volume :
- 117
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of the Egyptian Ophthalmological Society
- Publication Type :
- Academic Journal
- Accession number :
- 176412544
- Full Text :
- https://doi.org/10.4103/ejos.ejos_71_23